$AVPT
AvePoint, Inc. Stock $avpt

$avpt Overview Financials Valuation SEC Filings Company Website

2024 Q2 Form 10-Q Financial Statement

#000143774924015724 Filed on May 09, 2024

Income Statement

Concept	2024 Q2	2024 Q1
Revenue	$77.96M	$74.53M
YoY Change	20.18%	25.12%
Cost Of Revenue	$18.94M	$20.44M
YoY Change	-4.31%	14.26%
Gross Profit	$59.02M	$54.09M
YoY Change	30.94%	29.77%
Gross Profit Margin	75.7%	72.57%
Selling, General & Admin	$48.65M	$46.81M
YoY Change	13.45%	12.79%
% of Gross Profit	82.44%	86.53%
Research & Development	$12.50M	$10.49M
YoY Change	34.83%	16.32%
% of Gross Profit	21.18%	19.39%
Depreciation & Amortization	$1.328M	$1.295M
YoY Change	19.1%	14.2%
% of Gross Profit	2.25%	2.39%
Operating Expenses	$61.16M	$57.29M
YoY Change	17.26%	13.42%
Operating Profit	-$2.138M	-$3.201M
YoY Change	-69.82%	-63.76%
Interest Expense	-$607.0K	-$534.0K
YoY Change	-312.24%	-264.31%
% of Operating Profit
Other Income/Expense, Net	-$6.970M	$3.404M
YoY Change	-532.11%	141.08%
Pretax Income	-$9.108M	$203.0K
YoY Change	-1.13%	-102.82%
Income Tax	$3.830M	$2.157M
% Of Pretax Income		1062.56%
Net Earnings	-$12.94M	-$1.954M
YoY Change	2.8%	-78.75%
Net Earnings / Revenue	-16.6%	-2.62%
Basic Earnings Per Share	-$0.07	-$0.01
Diluted Earnings Per Share	-$0.07	-$0.01
COMMON SHARES
Basic Shares Outstanding	185.3M	184.0M
Diluted Shares Outstanding	182.8M	181.5M

Balance Sheet

Concept	2024 Q2	2024 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments	$230.8M	$219.3M
YoY Change	3.56%	-5.36%
Cash & Equivalents	$227.0M	$215.5M
Short-Term Investments	$3.842M	$3.795M
Other Short-Term Assets	$7.653M	$11.04M
YoY Change	38.17%	71.04%
Inventory
Prepaid Expenses	$4.800M	$6.000M
Receivables	$78.40M	$73.40M
Other Receivables	$0.00	$0.00
Total Short-Term Assets	$316.9M	$303.7M
YoY Change	9.18%	3.03%
LONG-TERM ASSETS
Property, Plant & Equipment	$4.522M	$4.906M
YoY Change	-9.49%	-5.22%
Goodwill	$18.48M	$18.69M
YoY Change	-2.65%	-0.95%
Intangibles	$9.809M	$10.17M
YoY Change	-8.92%	-6.3%
Long-Term Investments
YoY Change
Other Assets	$12.48M	$10.85M
YoY Change	45.72%	53.83%
Total Long-Term Assets	$110.4M	$110.1M
YoY Change	1.9%	3.16%
TOTAL ASSETS
Total Short-Term Assets	$316.9M	$303.7M
Total Long-Term Assets	$110.4M	$110.1M
Total Assets	$427.3M	$413.8M
YoY Change	7.2%	3.07%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$7.462M	$7.347M
YoY Change	418.55%	406.34%
Accrued Expenses	$47.34M	$40.92M
YoY Change	13.26%	16.72%
Deferred Revenue	$117.9M	$115.2M
YoY Change	22.84%	25.93%
Short-Term Debt	$0.00	$0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$172.7M	$163.5M
YoY Change	24.05%	27.72%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00
YoY Change
Other Long-Term Liabilities	$4.834M	$4.976M
YoY Change	-13.46%	-14.78%
Total Long-Term Liabilities	$4.834M	$4.976M
YoY Change	-13.46%	-14.78%
TOTAL LIABILITIES
Total Short-Term Liabilities	$172.7M	$163.5M
Total Long-Term Liabilities	$4.834M	$4.976M
Total Liabilities	$219.9M	$201.1M
YoY Change	26.76%	25.5%
SHAREHOLDERS EQUITY
Retained Earnings	-$485.3M	-$469.5M
YoY Change	7.67%	10.18%
Common Stock	$19.00K	$19.00K
YoY Change	0.0%	0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$205.9M	$212.7M
YoY Change
Total Liabilities & Shareholders Equity	$427.3M	$413.8M
YoY Change	7.2%	3.07%

Cashflow Statement

Concept	2024 Q2	2024 Q1
OPERATING ACTIVITIES
Net Income	-$12.94M	-$1.954M
YoY Change	2.8%	-78.75%
Depreciation, Depletion And Amortization	$1.328M	$1.295M
YoY Change	19.1%	14.2%
Cash From Operating Activities	$16.16M	$7.756M
YoY Change	101.82%	520.48%
INVESTING ACTIVITIES
Capital Expenditures	$394.0K	$502.0K
YoY Change	-30.14%	123.11%
Acquisitions
YoY Change
Other Investing Activities	-$651.0K	-$1.040M
YoY Change	-76.07%	-516.0%
Cash From Investing Activities	-$1.045M	-$1.542M
YoY Change	-68.18%	-278.89%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-2.859M	-$12.96M
YoY Change	-78.17%	1778.41%
NET CHANGE
Cash From Operating Activities	16.16M	$7.756M
Cash From Investing Activities	-1.045M	-$1.542M
Cash From Financing Activities	-2.859M	-$12.96M
Net Change In Cash	12.25M	-$7.673M
YoY Change	-246.37%	-568.15%
FREE CASH FLOW
Cash From Operating Activities	$16.16M	$7.756M
Capital Expenditures	$394.0K	$502.0K
Free Cash Flow	$15.76M	$7.254M
YoY Change	111.82%	607.71%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2024Q1	dei	Amendment Flag AmendmentFlag	false
CY2024Q1	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2024Q1	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q1
CY2024Q1	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2024
CY2024Q1	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	792000	usd
CY2023Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	926000	usd
CY2024Q1	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2023Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2024Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2023Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2024Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	1000000000
CY2023Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	1000000000
CY2024Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	185216000
CY2024Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	185216000
CY2023Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	184652000
CY2023Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	184652000
CY2023Q4	us-gaap	Goodwill Impaired Accumulated Impairment Loss GoodwillImpairedAccumulatedImpairmentLoss	0	usd
CY2024Q1	us-gaap	Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1 RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1	P12Y
CY2023Q4	us-gaap	Debt Instrument Variable Interest Rate Type Extensible Enumeration DebtInstrumentVariableInterestRateTypeExtensibleEnumeration	http://fasb.org/us-gaap/2024#SecuredOvernightFinancingRateSofrMember
CY2024Q1	avpt	Common Stock Shares Outstanding Including Treasury Shares CommonStockSharesOutstandingIncludingTreasuryShares	185215633
CY2023Q4	avpt	Common Stock Shares Outstanding Including Treasury Shares CommonStockSharesOutstandingIncludingTreasuryShares	184652402
CY2024Q1	us-gaap	Assets Fair Value Disclosure AssetsFairValueDisclosure	186251000	usd
CY2023Q4	us-gaap	Assets Fair Value Disclosure AssetsFairValueDisclosure	183358000	usd
CY2024Q1	us-gaap	Number Of Operating Segments NumberOfOperatingSegments	1	pure
CY2024Q1	ecd	Rule10b51 Arr Trmntd Flag Rule10b51ArrTrmntdFlag	false
CY2024Q1	ecd	Non Rule10b51 Arr Adopted Flag NonRule10b51ArrAdoptedFlag	false
CY2024Q1	ecd	Non Rule10b51 Arr Trmntd Flag NonRule10b51ArrTrmntdFlag	false
CY2024Q1	ecd	Trd Arr Adoption Date TrdArrAdoptionDate	March 4, 2024
CY2024Q1	ecd	Trd Arr Ind Name TrdArrIndName	Zhijian Lu
CY2024Q1	ecd	Trd Arr Ind Title TrdArrIndTitle	affiliate
CY2024Q1	ecd	Rule10b51 Arr Adopted Flag Rule10b51ArrAdoptedFlag	true
CY2024Q1	ecd	Trd Arr Expiration Date TrdArrExpirationDate	January 31, 2025
CY2024Q1	dei	Document Type DocumentType	10-Q
CY2024Q1	dei	Document Quarterly Report DocumentQuarterlyReport	true
CY2024Q1	dei	Document Period End Date DocumentPeriodEndDate	2024-03-31
CY2024Q1	dei	Document Transition Report DocumentTransitionReport	false
CY2024Q1	dei	Entity File Number EntityFileNumber	001-39048
CY2024Q1	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
CY2024Q1	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	83-4461709
CY2024Q1	dei	Entity Address Address Line1 EntityAddressAddressLine1	525 Washington Blvd, Suite 1400
CY2024Q1	dei	Entity Address City Or Town EntityAddressCityOrTown	Jersey City
CY2024Q1	dei	Entity Address State Or Province EntityAddressStateOrProvince	NJ
CY2024Q1	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	07310
CY2024Q1	dei	City Area Code CityAreaCode	804
CY2024Q1	dei	Local Phone Number LocalPhoneNumber	314-5903
CY2024Q1	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2024Q1	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2024Q1	dei	Entity Filer Category EntityFilerCategory	Large Accelerated Filer
CY2024Q1	dei	Entity Small Business EntitySmallBusiness	false
CY2024Q1	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2024Q1	dei	Entity Shell Company EntityShellCompany	false
CY2024Q2	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	185290143
CY2024Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	215489000	usd
CY2023Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	223162000	usd
CY2024Q1	us-gaap	Short Term Investments ShortTermInvestments	3795000	usd
CY2023Q4	us-gaap	Short Term Investments ShortTermInvestments	3721000	usd
CY2024Q1	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	73404000	usd
CY2023Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	85877000	usd
CY2024Q1	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	11037000	usd
CY2023Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	12824000	usd
CY2024Q1	us-gaap	Assets Current AssetsCurrent	303725000	usd
CY2023Q4	us-gaap	Assets Current AssetsCurrent	325584000	usd
CY2024Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	4906000	usd
CY2023Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	5118000	usd
CY2024Q1	us-gaap	Goodwill Goodwill	18692000	usd
CY2023Q4	us-gaap	Goodwill Goodwill	19156000	usd
CY2024Q1	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	10165000	usd
CY2023Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	10546000	usd
CY2024Q1	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	12887000	usd
CY2023Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	13908000	usd
CY2024Q1	us-gaap	Contract With Customer Asset Net Noncurrent ContractWithCustomerAssetNetNoncurrent	52595000	usd
CY2023Q4	us-gaap	Contract With Customer Asset Net Noncurrent ContractWithCustomerAssetNetNoncurrent	54675000	usd
CY2024Q1	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	10848000	usd
CY2023Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	13595000	usd
CY2024Q1	us-gaap	Assets Assets	413818000	usd
CY2023Q4	us-gaap	Assets Assets	442582000	usd
CY2024Q1	us-gaap	Accounts Payable Current AccountsPayableCurrent	7347000	usd
CY2023Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	1384000	usd
CY2024Q1	us-gaap	Accrued Liabilities And Other Liabilities AccruedLiabilitiesAndOtherLiabilities	40917000	usd
CY2023Q4	us-gaap	Accrued Liabilities And Other Liabilities AccruedLiabilitiesAndOtherLiabilities	53766000	usd
CY2024Q1	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	115197000	usd
CY2023Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	121515000	usd
CY2024Q1	us-gaap	Liabilities Current LiabilitiesCurrent	163461000	usd
CY2023Q4	us-gaap	Liabilities Current LiabilitiesCurrent	176665000	usd
CY2024Q1	us-gaap	Deferred Compensation Sharebased Arrangements Liability Classified Noncurrent DeferredCompensationSharebasedArrangementsLiabilityClassifiedNoncurrent	8121000	usd
CY2023Q4	us-gaap	Deferred Compensation Sharebased Arrangements Liability Classified Noncurrent DeferredCompensationSharebasedArrangementsLiabilityClassifiedNoncurrent	9383000	usd
CY2024Q1	us-gaap	Contract With Customer Liability Noncurrent ContractWithCustomerLiabilityNoncurrent	7372000	usd
CY2023Q4	us-gaap	Contract With Customer Liability Noncurrent ContractWithCustomerLiabilityNoncurrent	7741000	usd
CY2024Q1	us-gaap	Business Combination Contingent Consideration Liability Noncurrent BusinessCombinationContingentConsiderationLiabilityNoncurrent	17140000	usd
CY2023Q4	us-gaap	Business Combination Contingent Consideration Liability Noncurrent BusinessCombinationContingentConsiderationLiabilityNoncurrent	18346000	usd
CY2024Q1	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	4976000	usd
CY2023Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	5603000	usd
CY2024Q1	us-gaap	Liabilities Liabilities	201070000	usd
CY2023Q4	us-gaap	Liabilities Liabilities	217738000	usd
CY2024Q1	us-gaap	Redeemable Noncontrolling Interest Equity Carrying Amount RedeemableNoncontrollingInterestEquityCarryingAmount	0	usd
CY2023Q4	us-gaap	Redeemable Noncontrolling Interest Equity Carrying Amount RedeemableNoncontrollingInterestEquityCarryingAmount	6038000	usd
CY2024Q1	us-gaap	Temporary Equity Carrying Amount Including Portion Attributable To Noncontrolling Interests TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests	0	usd
CY2023Q4	us-gaap	Temporary Equity Carrying Amount Including Portion Attributable To Noncontrolling Interests TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests	6038000	usd
CY2024Q1	us-gaap	Common Stock Value CommonStockValue	19000	usd
CY2023Q4	us-gaap	Common Stock Value CommonStockValue	18000	usd
CY2024Q1	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	677926000	usd
CY2023Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	667881000	usd
CY2024Q1	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	2693000	usd
CY2023Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	3196000	usd
CY2024Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-469517000	usd
CY2023Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-460496000	usd
CY2024Q1	us-gaap	Minority Interest MinorityInterest	1627000	usd
CY2023Q4	us-gaap	Minority Interest MinorityInterest	8207000	usd
CY2024Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	212748000	usd
CY2023Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	218806000	usd
CY2024Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	413818000	usd
CY2023Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	442582000	usd
CY2024Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	74534000	usd
CY2023Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	59572000	usd
CY2024Q1	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	20442000	usd
CY2023Q1	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	17890000	usd
CY2024Q1	us-gaap	Gross Profit GrossProfit	54092000	usd
CY2023Q1	us-gaap	Gross Profit GrossProfit	41682000	usd
CY2024Q1	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	29939000	usd
CY2023Q1	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	26851000	usd
CY2024Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	16868000	usd
CY2023Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	14648000	usd
CY2024Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	10486000	usd
CY2023Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	9015000	usd
CY2024Q1	us-gaap	Operating Expenses OperatingExpenses	57293000	usd
CY2023Q1	us-gaap	Operating Expenses OperatingExpenses	50514000	usd
CY2024Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-3201000	usd
CY2023Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-8832000	usd
CY2024Q1	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	3404000	usd
CY2023Q1	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	1628000	usd
CY2024Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	203000	usd
CY2023Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-7204000	usd
CY2024Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	2157000	usd
CY2023Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	1978000	usd
CY2024Q1	us-gaap	Profit Loss ProfitLoss	-1954000	usd
CY2023Q1	us-gaap	Profit Loss ProfitLoss	-9182000	usd
CY2024Q1	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-238000	usd
CY2023Q1	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	15000	usd
CY2024Q1	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-1716000	usd
CY2023Q1	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-9197000	usd
CY2024Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.01
CY2023Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.05
CY2024Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	181495000
CY2023Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	182818000
CY2024Q1	us-gaap	Profit Loss ProfitLoss	-1954000	usd
CY2023Q1	us-gaap	Profit Loss ProfitLoss	-9182000	usd
CY2024Q1	us-gaap	Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Net Of Tax OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax	100000	usd
CY2023Q1	us-gaap	Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Net Of Tax OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax	-0	usd
CY2024Q1	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-478000	usd
CY2023Q1	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	84000	usd
CY2024Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-578000	usd
CY2023Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	84000	usd
CY2024Q1	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	-2532000	usd
CY2023Q1	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	-9098000	usd
CY2024Q1	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	-311000	usd
CY2023Q1	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	50000	usd
CY2024Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-2221000	usd
CY2023Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-9148000	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	218806000	usd
CY2024Q1	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	784000	usd
CY2024Q1	us-gaap	Stock Issued During Period Value Restricted Stock Award Gross StockIssuedDuringPeriodValueRestrictedStockAwardGross	0	usd
CY2024Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	9458000	usd
CY2024Q1	us-gaap	Temporary Equity Accretion Of Interest TemporaryEquityAccretionOfInterest	99000	usd
CY2024Q1	us-gaap	Minority Interest Decrease From Redemptions MinorityInterestDecreaseFromRedemptions	-0	usd
CY2024Q1	avpt	Reclassifications Of Earn Out Rs Us To Earn Out Shares ReclassificationsOfEarnOutRSUsToEarnOutShares	137000	usd
CY2024Q1	us-gaap	Stock Repurchased And Retired During Period Value StockRepurchasedAndRetiredDuringPeriodValue	13743000	usd
CY2024Q1	avpt	Net Income Loss Before Amount Attributable To Mezzanine Equity NetIncomeLossBeforeAmountAttributableToMezzanineEquity	-1949000	usd
CY2024Q1	us-gaap	Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Net Of Tax OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax	100000	usd
CY2024Q1	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	-470000	usd
CY2024Q1	us-gaap	Stockholders Equity StockholdersEquity	212748000	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	229147000	usd
CY2023Q1	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	1131000	usd
CY2023Q1	us-gaap	Stock Issued During Period Value Restricted Stock Award Gross StockIssuedDuringPeriodValueRestrictedStockAwardGross	0	usd
CY2023Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	8104000	usd
CY2023Q1	avpt	Reclassifications Of Earn Out Rs Us To Earn Out Shares ReclassificationsOfEarnOutRSUsToEarnOutShares	182000	usd
CY2023Q1	us-gaap	Treasury Stock Value Acquired Cost Method TreasuryStockValueAcquiredCostMethod	1811000	usd
CY2023Q1	avpt	Net Income Loss Before Amount Attributable To Mezzanine Equity NetIncomeLossBeforeAmountAttributableToMezzanineEquity	-9182000	usd
CY2023Q1	us-gaap	Net Income Loss Attributable To Redeemable Noncontrolling Interest NetIncomeLossAttributableToRedeemableNoncontrollingInterest	15000	usd
CY2023Q1	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	49000	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	227241000	usd
CY2024Q1	us-gaap	Profit Loss ProfitLoss	-1954000	usd
CY2024Q1	avpt	Depreciation Depletion And Amortization Including Amortization Of Intangible Assets DepreciationDepletionAndAmortizationIncludingAmortizationOfIntangibleAssets	1295000	usd
CY2023Q1	avpt	Depreciation Depletion And Amortization Including Amortization Of Intangible Assets DepreciationDepletionAndAmortizationIncludingAmortizationOfIntangibleAssets	1134000	usd
CY2024Q1	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	1420000	usd
CY2023Q1	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	1749000	usd
CY2024Q1	avpt	Foreign Currency Remeasurement Gain Loss ForeignCurrencyRemeasurementGainLoss	-580000	usd
CY2023Q1	avpt	Foreign Currency Remeasurement Gain Loss ForeignCurrencyRemeasurementGainLoss	175000	usd
CY2024Q1	us-gaap	Share Based Compensation ShareBasedCompensation	9458000	usd
CY2023Q1	us-gaap	Share Based Compensation ShareBasedCompensation	8104000	usd
CY2024Q1	us-gaap	Deferred Income Taxes And Tax Credits DeferredIncomeTaxesAndTaxCredits	-72000	usd
CY2023Q1	us-gaap	Profit Loss ProfitLoss	-9182000	usd
CY2023Q1	us-gaap	Deferred Income Taxes And Tax Credits DeferredIncomeTaxesAndTaxCredits	-82000	usd
CY2024Q1	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	146000	usd
CY2023Q1	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	1566000	usd
CY2024Q1	avpt	Gain Loss On Change In Contingent Liability And Warrants Excluding General And Administrative Expense GainLossOnChangeInContingentLiabilityAndWarrantsExcludingGeneralAndAdministrativeExpense	1490000	usd
CY2023Q1	avpt	Gain Loss On Change In Contingent Liability And Warrants Excluding General And Administrative Expense GainLossOnChangeInContingentLiabilityAndWarrantsExcludingGeneralAndAdministrativeExpense	-109000	usd
CY2024Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-10933000	usd
CY2023Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-10049000	usd
CY2024Q1	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-1718000	usd
CY2023Q1	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-3571000	usd
CY2024Q1	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	-4447000	usd
CY2023Q1	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	-2987000	usd
CY2024Q1	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-14293000	usd
CY2023Q1	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-12828000	usd
CY2024Q1	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	-4140000	usd
CY2023Q1	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	-2620000	usd
CY2024Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	7756000	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	1250000	usd
CY2024Q1	us-gaap	Proceeds From Maturities Prepayments And Calls Of Shortterm Investments ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments	240000	usd
CY2023Q1	us-gaap	Proceeds From Maturities Prepayments And Calls Of Shortterm Investments ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments	1670000	usd
CY2024Q1	us-gaap	Payments To Acquire Short Term Investments PaymentsToAcquireShortTermInvestments	389000	usd
CY2023Q1	us-gaap	Payments To Acquire Short Term Investments PaymentsToAcquireShortTermInvestments	74000	usd
CY2024Q1	us-gaap	Payments For Software PaymentsForSoftware	391000	usd
CY2023Q1	us-gaap	Payments For Software PaymentsForSoftware	259000	usd
CY2024Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	502000	usd
CY2023Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	225000	usd
CY2024Q1	us-gaap	Payments To Acquire Notes Receivable PaymentsToAcquireNotesReceivable	500000	usd
CY2023Q1	us-gaap	Payments To Acquire Notes Receivable PaymentsToAcquireNotesReceivable	250000	usd
CY2024Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-1542000	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	862000	usd
CY2024Q1	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	13743000	usd
CY2023Q1	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	1811000	usd
CY2024Q1	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	784000	usd
CY2023Q1	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	1131000	usd
CY2024Q1	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	2000	usd
CY2023Q1	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	10000	usd
CY2024Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-12961000	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-690000	usd
CY2024Q1	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	-926000	usd
CY2023Q1	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	217000	usd
CY2024Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-7673000	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	1639000	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	223162000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	227188000	usd
CY2024Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	215489000	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	228827000	usd
CY2024Q1	us-gaap	Interest Paid Net InterestPaidNet	984000	usd
CY2023Q1	us-gaap	Interest Paid Net InterestPaidNet	327000	usd
CY2024Q1	avpt	Unpaid Redemption Of Noncontrolling Interest UnpaidRedemptionOfNoncontrollingInterest	5926000	usd
CY2023Q1	avpt	Unpaid Redemption Of Noncontrolling Interest UnpaidRedemptionOfNoncontrollingInterest	0	usd
CY2024Q1	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	-600000	usd
CY2023Q1	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	-300000	usd
CY2024Q1	us-gaap	Nature Of Operations NatureOfOperations	<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt;"><b><em style="font: inherit;">1.</em> Nature of Business and Organization </b></p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify; text-indent: 36pt;">AvePoint, Inc. (collectively with its subsidiaries, hereinafter referred to as “<i><b>AvePoint</b></i>,” the “<i><b>Company</b></i>,” “<i><b>we</b></i>,” “<i><b>us</b></i>,” or “<i><b>our</b></i>”) was incorporated as a New Jersey corporation on <em style="font: inherit;"> July 24, 2001 </em>and redomiciled as a Delaware corporation in <em style="font: inherit;">2006.</em></p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt; text-indent: 36pt;">AvePoint provides a cloud-native software platform that organizations rely on to optimize operations, manage critical data and secure the digital workplace. As companies around the world embrace the new normal of hybrid work, they must build and deliver a new, seamless workplace experience for knowledge workers, centered around an extensive portfolio of SaaS solutions and productivity applications aimed at improving collaboration across the organization.</p> <p style="font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;"> </p> <p style="font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">Our principal corporate headquarters are located in Jersey City, New Jersey, with our principal operating headquarters in Richmond, Virginia and additional offices in North America, Europe, Asia, Australia and the Middle East.</p>
CY2024Q1	us-gaap	Prior Period Reclassification Adjustment Description PriorPeriodReclassificationAdjustmentDescription	<p style="font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin: 0pt;"><b><i><span style="text-decoration: underline; ">Comparative Data</span></i></b></p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify; text-indent: 36pt;">Certain amounts from prior periods have been reclassed to conform to the current period presentation, including:</p> <p style="font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify; text-indent: 36pt;"> </p> <table border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt; font-family: "Times New Roman", Times, serif; width: 100%;"><tbody><tr><td style="width: 3%;"> </td><td style="width: 3%; padding: 0px; vertical-align: top;">•</td><td style="width: 94%; text-align: justify;">The reclassification of gain (loss) on earn-out and warrant liabilities to be included in other income, net on the condensed consolidated statements of operations for the <em style="font: inherit;">three</em> months ended <em style="font: inherit;"> March 31, 2023.</em></td></tr> <tr><td style="width: 3%;"> </td><td style="width: 3%; padding: 0px; vertical-align: top;">•</td><td style="width: 94%; text-align: justify;">The reclassification of interest income, net to be included in other income, net on the condensed consolidated statements of operations for the <em style="font: inherit;">three</em> months ended <em style="font: inherit;"> March 31, 2023.</em></td></tr> </tbody></table> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p>
CY2024Q1	us-gaap	Use Of Estimates UseOfEstimates	<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"><b><i><span style="text-decoration: underline; ">Use of Estimates</span></i></b></p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt; text-indent: 36pt;">The preparation of condensed consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the amounts reported in our condensed consolidated financial statements and accompanying notes. We base our estimates and assumptions on historical experience and on various other assumptions that we believe are reasonable under the circumstances. The amounts of assets and liabilities reported in our condensed consolidated balance sheets and the amounts of revenue and expenses reported for each of the periods presented are affected by estimates and assumptions, which are used for, but <em style="font: inherit;">not</em> limited to, the accounting for the determination of standalone selling price for revenue recognition, allowance of doubtful accounts, deferred contract costs, valuation of goodwill and other intangible assets, income taxes and related reserves, stock-based compensation, purchase price in a business combination, and earn-out liabilities. Actual results and outcomes <em style="font: inherit;"> may </em>differ from management’s estimates and assumptions due to risks and uncertainties. </p> <p style="font-family: "Times New Roman"; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify; text-indent: 36pt;"> </p>
CY2024Q1	us-gaap	Cash Cash	9100000	usd
CY2023Q4	us-gaap	Cash Cash	13100000	usd
CY2024Q1	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	6000000	usd
CY2023Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	7600000	usd
CY2024Q1	us-gaap	Goodwill Impaired Accumulated Impairment Loss GoodwillImpairedAccumulatedImpairmentLoss	0	usd
CY2024Q1	us-gaap	Capitalized Contract Cost Amortization CapitalizedContractCostAmortization	5300000	usd
CY2023Q1	us-gaap	Capitalized Contract Cost Amortization CapitalizedContractCostAmortization	4200000	usd
CY2024Q1	us-gaap	Capitalized Contract Cost Net CapitalizedContractCostNet	52600000	usd
CY2023Q4	us-gaap	Capitalized Contract Cost Net CapitalizedContractCostNet	54700000	usd
CY2024Q1	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	122600000	usd
CY2023Q4	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	129300000	usd
CY2024Q1	us-gaap	Contract With Customer Liability Revenue Recognized ContractWithCustomerLiabilityRevenueRecognized	46600000	usd
CY2023Q4	us-gaap	Accounts Receivable Net AccountsReceivableNet	94067000	usd
CY2023Q4	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	129256000	usd
CY2023Q4	us-gaap	Capitalized Contract Cost Net CapitalizedContractCostNet	54675000	usd
CY2024Q1	us-gaap	Accounts Receivable Net AccountsReceivableNet	78488000	usd
CY2024Q1	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	122569000	usd
CY2024Q1	us-gaap	Capitalized Contract Cost Net CapitalizedContractCostNet	52595000	usd
CY2024Q1	us-gaap	Revenue Remaining Performance Obligation RevenueRemainingPerformanceObligation	309700000	usd
CY2024Q1	us-gaap	Revenue Remaining Performance Obligation Percentage RevenueRemainingPerformanceObligationPercentage	0.61	pure
CY2023Q4	us-gaap	Goodwill Goodwill	19156000	usd
CY2024Q1	us-gaap	Goodwill Acquired During Period GoodwillAcquiredDuringPeriod	0	usd
CY2024Q1	us-gaap	Goodwill Foreign Currency Translation Gain Loss GoodwillForeignCurrencyTranslationGainLoss	-464000	usd
CY2024Q1	us-gaap	Goodwill Goodwill	18692000	usd
CY2024Q1	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	600000	usd
CY2023Q1	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	500000	usd
CY2024Q1	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	13527000	usd
CY2024Q1	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	3362000	usd
CY2024Q1	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	10165000	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	13365000	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	2819000	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	10546000	usd
CY2024Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear	1808000	usd
CY2024Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Next Twelve Months FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths	2048000	usd
CY2024Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Two FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	1556000	usd
CY2024Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Three FiniteLivedIntangibleAssetsAmortizationExpenseYearThree	1169000	usd
CY2024Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Four FiniteLivedIntangibleAssetsAmortizationExpenseYearFour	994000	usd
CY2024Q1	avpt	Finitelived Intangible Asset Expected Amortization After Year Four FinitelivedIntangibleAssetExpectedAmortizationAfterYearFour	2590000	usd
CY2024Q1	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	10165000	usd
CY2024Q1	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	792000	usd
CY2023Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	926000	usd
CY2024Q1	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	73404000	usd
CY2023Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	85877000	usd
CY2024Q1	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	10.626	pure
CY2023Q1	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.275	pure
CY2024Q1	us-gaap	Operating Lease Cost OperatingLeaseCost	1720000	usd
CY2023Q1	us-gaap	Operating Lease Cost OperatingLeaseCost	1749000	usd
CY2024Q1	us-gaap	Short Term Lease Cost ShortTermLeaseCost	267000	usd
CY2023Q1	us-gaap	Short Term Lease Cost ShortTermLeaseCost	248000	usd
CY2024Q1	us-gaap	Variable Lease Cost VariableLeaseCost	135000	usd
CY2023Q1	us-gaap	Variable Lease Cost VariableLeaseCost	110000	usd
CY2024Q1	us-gaap	Lease Cost LeaseCost	2122000	usd
CY2023Q1	us-gaap	Lease Cost LeaseCost	2107000	usd
CY2024Q1	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	700000	usd
CY2023Q1	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	2600000	usd
CY2024Q1	us-gaap	Operating Lease Payments OperatingLeasePayments	2124000	usd
CY2023Q1	us-gaap	Operating Lease Payments OperatingLeasePayments	2046000	usd
CY2024Q1	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P3Y8M12D
CY2024Q1	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.056	pure
CY2023Q4	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P3Y9M18D
CY2023Q4	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.056	pure
CY2024Q1	us-gaap	Lessee Operating Lease Liability Payments Remainder Of Fiscal Year LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear	4132000	usd
CY2024Q1	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	4381000	usd
CY2024Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	2492000	usd
CY2024Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	1707000	usd
CY2024Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	786000	usd
CY2024Q1	avpt	Lessee Operating Lease Liability To Be Paid After Year Four LesseeOperatingLeaseLiabilityToBePaidAfterYearFour	1212000	usd
CY2024Q1	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	14710000	usd
CY2024Q1	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	1418000	usd
CY2024Q1	us-gaap	Operating Lease Liability OperatingLeaseLiability	13292000	usd
CY2024Q1	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	5200000	usd
CY2021Q3	avpt	Number Of Shares Exchangeable At1250 NumberOfSharesExchangeableAt1250	1000000
CY2021Q3	avpt	Number Of Shares Exchangeable At1500 NumberOfSharesExchangeableAt1500	1000000
CY2021Q3	avpt	Number Of Shares Exchangeable At1750 NumberOfSharesExchangeableAt1750	1000000
CY2021Q3	us-gaap	Business Combination Contingent Consideration Liability BusinessCombinationContingentConsiderationLiability	29600000	usd
CY2024Q1	us-gaap	Business Combination Contingent Consideration Liability BusinessCombinationContingentConsiderationLiability	17100000	usd
CY2023Q4	us-gaap	Business Combination Contingent Consideration Liability BusinessCombinationContingentConsiderationLiability	18300000	usd
CY2024Q1	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	1300000	usd
CY2023Q1	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	100000	usd
CY2023Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	1000000000
CY2023Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2024Q1	avpt	Common Stock Shares Issued Including Treasury Shares CommonStockSharesIssuedIncludingTreasuryShares	185215633
CY2023Q4	avpt	Common Stock Shares Issued Including Treasury Shares CommonStockSharesIssuedIncludingTreasuryShares	184652402
CY2024Q1	srt	Stock Repurchase Program Authorized Amount1 StockRepurchaseProgramAuthorizedAmount1	150000000	usd
CY2024Q1	us-gaap	Stock Repurchased And Retired During Period Shares StockRepurchasedAndRetiredDuringPeriodShares	1758850
CY2024Q1	us-gaap	Treasury Stock Acquired Average Cost Per Share TreasuryStockAcquiredAverageCostPerShare	7.81
CY2023Q1	us-gaap	Treasury Stock Shares Acquired TreasuryStockSharesAcquired	424876
CY2023Q1	us-gaap	Treasury Stock Shares Retired TreasuryStockSharesRetired	0
CY2021Q3	avpt	Number Of Shares Subject To Vesting Provision NumberOfSharesSubjectToVestingProvision	2916700
CY2023	avpt	Number Of Shares Subject To Vesting Provision NumberOfSharesSubjectToVestingProvision	0
CY2024Q1	avpt	Business Acquisition Conditional Option To Repurchase Shares BusinessAcquisitionConditionalOptionToRepurchaseShares	0	usd
CY2024Q1	us-gaap	Redeemable Noncontrolling Interest Equity Carrying Amount RedeemableNoncontrollingInterestEquityCarryingAmount	0	usd
CY2024Q1	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions	13500000	usd
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	26813324
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	22139333
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	106700000	usd
CY2024Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1	97700000	usd
CY2024Q1	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	293361
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	1500000	usd
CY2024Q1	us-gaap	Money Market Funds At Carrying Value MoneyMarketFundsAtCarryingValue	178581000	usd
CY2024Q1	us-gaap	Liabilities Fair Value Disclosure LiabilitiesFairValueDisclosure	17526000	usd
CY2023Q4	us-gaap	Liabilities Fair Value Disclosure LiabilitiesFairValueDisclosure	18879000	usd
CY2024Q1	us-gaap	Profit Loss ProfitLoss	-1954000	usd
CY2023Q1	us-gaap	Profit Loss ProfitLoss	-9182000	usd
CY2024Q1	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-238000	usd
CY2023Q1	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	15000	usd
CY2024Q1	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-1716000	usd
CY2023Q1	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-9197000	usd
CY2024Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	181495000
CY2024Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	74534000	usd
CY2023Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	59572000	usd
CY2024Q1	us-gaap	Gain Loss On Derivative Instruments Net Pretax GainLossOnDerivativeInstrumentsNetPretax	1490000	usd
CY2023Q1	us-gaap	Gain Loss On Derivative Instruments Net Pretax GainLossOnDerivativeInstrumentsNetPretax	-109000	usd
CY2024Q1	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	34000	usd
CY2023Q1	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	325000	usd
CY2024Q1	us-gaap	Marketable Securities Gain Loss Excluding Other Than Temporary Impairments MarketableSecuritiesGainLossExcludingOtherThanTemporaryImpairments	2417000	usd
CY2023Q1	us-gaap	Marketable Securities Gain Loss Excluding Other Than Temporary Impairments MarketableSecuritiesGainLossExcludingOtherThanTemporaryImpairments	1670000	usd
CY2024Q1	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	-568000	usd
CY2023Q1	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	-286000	usd
CY2024Q1	us-gaap	Other Income OtherIncome	31000	usd
CY2023Q1	us-gaap	Other Income OtherIncome	28000	usd
CY2024Q1	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	3404000	usd
CY2023Q1	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	1628000	usd
CY2023Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	182818000
CY2024Q1	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	0
CY2023Q1	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	0
CY2024Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	181495000
CY2023Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	182818000
CY2024Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.01
CY2023Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.05
CY2024Q1	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	60112000
CY2023Q1	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	63588000
CY2024Q1	ecd	Trd Arr Securities Agg Avail Amt TrdArrSecuritiesAggAvailAmt	480000

Files In Submission

Name	View Source	Status
avpt-20240331_cal.xml	Edgar Link	unprocessable
0001437749-24-015724-index-headers.html	Edgar Link	pending
0001437749-24-015724-index.html	Edgar Link	pending
0001437749-24-015724.txt	Edgar Link	pending
0001437749-24-015724-xbrl.zip	Edgar Link	pending
avpt-20240331.xsd	Edgar Link	pending
avpt20240331_10q.htm	Edgar Link	pending
ex_648792.htm	Edgar Link	pending
ex_648793.htm	Edgar Link	pending
ex_648794.htm	Edgar Link	pending
ex_648795.htm	Edgar Link	pending
ex_649998.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
avpt-20240331_def.xml	Edgar Link	unprocessable
avpt-20240331_lab.xml	Edgar Link	unprocessable
avpt-20240331_pre.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable
avpt20240331_10q_htm.xml	Edgar Link	completed
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$AVPT
AvePoint, Inc. Stock $avpt

2024 Q2 Form 10-Q Financial Statement

#000143774924015724 Filed on May 09, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$AVPT AvePoint, Inc. Stock $avpt

2024 Q2 Form 10-Q Financial Statement

#000143774924015724 Filed on May 09, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$AVPT
AvePoint, Inc. Stock $avpt